IL1RL1 and Hypertension: The array of systemic changes in CVD-related biomarkers included increased blood levels of hypertension marker aldosterone (Fig 3A), elevated FABP3, a biomarker of heart pathology (Fig 3B), and significantly increased vascular markers IL-16 (Fig 3C) and ST2 (Fig 3D).